HIV News and Research RSS Feed - HIV News and Research

MSH mobilizes resources to strengthen Liberia’s health system, limit spread of Ebola

MSH mobilizes resources to strengthen Liberia’s health system, limit spread of Ebola

Management Sciences for Health (MSH), a Massachusetts-based global health nonprofit organization, today announced it is mobilizing its expertise and resources at the epicenter of the Ebola epidemic in Liberia to help the Ministry of Health develop community care centers for Ebola separate from the health facilities; restore essential health services for non-Ebola patients; and, improve the detection and containment of active Ebola cases in Liberian communities. [More]
Antibiotic stewardship programs reduce length of stay and hospital readmission in children

Antibiotic stewardship programs reduce length of stay and hospital readmission in children

Hospitalized children go home sooner and are less likely to be readmitted when the hospital has an antibiotic stewardship program that's dedicated to controlling antibiotic prescriptions and treatment, according to a study being presented at IDWeek 2014-. The study is the first to show the benefits of such programs on children's health. [More]
RBX2660 drug candidate highly effective against recurrent Clostridium difficile infection

RBX2660 drug candidate highly effective against recurrent Clostridium difficile infection

Rebiotix Inc. announced today that results of the Phase 2 PUNCH CD Study found that the overall efficacy of RBX2660 in the treatment of recurrent Clostridium difficile infection was 87.1%. The study also found that administration of RBX2660 was well-tolerated and demonstrated satisfactory safety in the 60-day interim analysis. [More]
NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

NanoBio Corporation today announced that the company will present data at The Keystone Symposia Conference, The Modes of Action of Vaccine Adjuvants, in Seattle on October 12, 2014. [More]
CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors. [More]
KNCV becomes prime partner for USAID's flagship tuberculosis program

KNCV becomes prime partner for USAID's flagship tuberculosis program

KNCV Tuberculosis Foundation, the Dutch NGO specialized in the fight against tuberculosis, will be the prime partner for the United States Agency for International Development in their new five year flagship program 'Challenge TB'. [More]
Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Astellas reported today that isavuconazole demonstrated successful outcomes in the treatment of mucormycosis according to data from the phase 3 isavuconazole VITAL study being presented at IDWeek on October 10, 2014, in Philadelphia, Pa. [More]
Researchers use computer based predictions to combat AIDS

Researchers use computer based predictions to combat AIDS

The battle against AIDS cannot be won in the laboratory alone. To fight the potentially deadly virus that 34 million people are suffering from we need help from computers. [More]
Revolutionary Hypo-tec Needlestick Injury Prevention Product enters North American market

Revolutionary Hypo-tec Needlestick Injury Prevention Product enters North American market

V3 Healthcare Strategies, a Wisconsin-based Accountable Care Strategies company, announced the North American launch of the revolutionary Hypo-tec Needlestick Injury Prevention Product amidst an environment of infectious catastrophic diseases such as Ebola, Hanta & Hemorrhagic Fevers, while simultaneously protecting against all other infectious diseases such as HIV/AIDS, Hepatitis and more. [More]
Viewpoints: Relatively few face insurance cancellations; new doctor payment site is 'impenetrable'

Viewpoints: Relatively few face insurance cancellations; new doctor payment site is 'impenetrable'

People are starting to get letters telling them their health insurance plans have been canceled because of the Affordable Care Act. Because the letters will go out just before the midterm congressional elections, they are likely to get a lot of attention. There have been several stories this past week. But the people affected will represent only a small fraction of the population with health insurance (Margot Sanger-Katz, (10/6). [More]
New drug discovery tool against Ebola virus

New drug discovery tool against Ebola virus

University of Utah biochemists have reported a new drug discovery tool against the Ebola virus. According to a study published in this week's online edition of Protein Science, they have produced a molecule, known as a peptide mimic, that displays a functionally critical region of the virus that is universally conserved in all known species of Ebola. [More]
TRU-D SmartUVC’s Ebola-killing UVC automated disinfection robot to be showcased at IDWeek 2014

TRU-D SmartUVC’s Ebola-killing UVC automated disinfection robot to be showcased at IDWeek 2014

TRU-D SmartUVC LLC will feature its Ebola-killing UVC automated disinfection robot at IDWeek 2014 in Philadelphia this week from October 8 to 12 at booth 826. [More]
First three recipients of inaugural Harry Winston Fellowships named

First three recipients of inaugural Harry Winston Fellowships named

Harry Winston, Inc. and the UCLA Children's Discovery and Innovation Institute have named the first three recipients of the inaugural Harry Winston Fellowships. [More]
Penn Medicine to explore therapeutic strategies for HIV positive women at risk of cervical cancer

Penn Medicine to explore therapeutic strategies for HIV positive women at risk of cervical cancer

The introduction of antiretroviral drugs in Botswana over the last two decades has increased the life expectancies of people living with HIV—many of whom are women co-infected with the human papillomavirus virus (HPV)—considerably: from 39 years to the low 60s. As a result, this co-infected group of women is at a much higher risk of developing HPV-associated cervical cancer. [More]
AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

The international research & development (R&D) consortium, AfriCoLeish, formed by six research organizations from East Africa and Europe, has launched a Phase III clinical study to address the extreme difficulty in treating visceral leishmaniasis (VL) in patients who also are HIV-positive. [More]
Researchers find potential new way to better control immune-mediated diseases

Researchers find potential new way to better control immune-mediated diseases

Researchers at University of California, San Diego School of Medicine have discovered that T-cells - a type of white blood cell that learns to recognize and attack microbial pathogens - are activated by a pain receptor. [More]
Vitamin D supplement significantly reduces symptoms of winter-related atopic dermatitis

Vitamin D supplement significantly reduces symptoms of winter-related atopic dermatitis

A study conducted in more than 100 Mongolian schoolchildren found that daily treatment with a vitamin D supplement significantly reduced the symptoms of winter-related atopic dermatitis, a type of eczema. [More]
Blackflies infected with Onchocerca volvulus parasite may spread nodding syndrome

Blackflies infected with Onchocerca volvulus parasite may spread nodding syndrome

Despite decades of research, scientists have yet to pinpoint the exact cause of nodding syndrome (NS), a disabling disease affecting African children. A new report suggests that blackflies infected with the parasite Onchocerca volvulus may be capable of passing on a secondary pathogen that is to blame for the spread of the disease. New research is presented in the International Journal of Infectious Diseases. [More]
Genetic history of HIV finally unravelled

Genetic history of HIV finally unravelled

Research, published today, shows that the HIV pandemic almost certainly began its global spread in the 1920s in Kinshasa in the Democratic Republic of Congo. [More]
Longer looks: Dying at home; losing religion; Obamacare 2.0

Longer looks: Dying at home; losing religion; Obamacare 2.0

He was still her handsome father, the song-and-dance man of her childhood, with a full head of wavy hair and blue eyes that lit up when he talked. But he was gaunt now, warped like a weathered plank, perhaps by late effects of an old stroke, certainly by muscle atrophy and bad circulation in his legs. Now she was determined to fulfill her father's dearest wish, the wish so common among frail, elderly people: to die at home. But it seemed as if all the forces of the health care system were against her -; hospitals, nursing homes, home health agencies, insurance companies, and the shifting crosscurrents of public health care spending (Nina Bernstein, 9/25). [More]